Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

1.

The clinical and histological features of transitional cell carcinoma of the bladder with microcysts: analysis of 12 cases.

Paz A, Rath-Wolfson L, Lask D, Koren R, Manes A, Mukamel E, Gal R.

Br J Urol. 1997 May;79(5):722-5.

PMID:
9158509
[PubMed - indexed for MEDLINE]
2.

The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder.

Chen SS, Chen KK, Lin AT, Chang YH, Wu HH, Hsu TH, Chang LS.

Br J Urol. 1996 Aug;78(2):209-12.

PMID:
8813915
[PubMed - indexed for MEDLINE]
3.

Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma.

Amin MB, Ro JY, el-Sharkawy T, Lee KM, Troncoso P, Silva EG, Ordóñez NG, Ayala AG.

Am J Surg Pathol. 1994 Dec;18(12):1224-32.

PMID:
7977945
[PubMed - indexed for MEDLINE]
4.

Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.

Raman JD, Sosa RE, Vaughan ED Jr, Scherr DS.

Urology. 2007 Feb;69(2):251-4.

PMID:
17320658
[PubMed - indexed for MEDLINE]
5.

Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.

Ro JY, Shen SS, Lee HI, Hong EK, Lee YH, Cho NH, Jung SJ, Choi YJ, Ayala AG.

Am J Surg Pathol. 2008 May;32(5):752-7. doi: 10.1097/PAS.0b013e318159af9e.

PMID:
18379419
[PubMed - indexed for MEDLINE]
6.

Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.

Chou EC, Lin AT, Chen KK, Chang LS.

Int J Urol. 2006 Jun;13(6):682-5.

PMID:
16834642
[PubMed - indexed for MEDLINE]
7.

Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success.

Lebret T, Gaudez F, Hervé JM, Barré P, Lugagne PM, Botto H.

Eur Urol. 1998;34(1):67-72.

PMID:
9676417
[PubMed - indexed for MEDLINE]
8.

Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.

Elsamman E, Fukumori T, Kasai T, Nakatsuji H, Nishitani MA, Toida K, Ali N, Kanayama HO.

BJU Int. 2006 Jun;97(6):1202-7.

PMID:
16686711
[PubMed - indexed for MEDLINE]
9.

Bladder cancer in Sri Lanka: experience from a tertiary referral center.

Goonewardena SA, De Silva WA, De Silva MV.

Int J Urol. 2004 Nov;11(11):969-72.

PMID:
15509199
[PubMed - indexed for MEDLINE]
10.

Conservative treatment of high grade superficial bladder tumours.

Trinchieri A, Bonacina P, Butti A, Cappoli S, Esposito N, Invernizzi S, Librizzi A, Locatelli G.

Arch Ital Urol Androl. 2005 Dec;77(4):215-8.

PMID:
16444936
[PubMed - indexed for MEDLINE]
11.

A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years.

Larsson P, Wijkström H, Thorstenson A, Adolfsson J, Norming U, Wiklund P, Onelöv E, Steineck G.

Scand J Urol Nephrol. 2003;37(3):195-201.

PMID:
12775276
[PubMed - indexed for MEDLINE]
12.

Clinical outcome of conservative therapy for stage T1, grade 3 transitional cell carcinoma of the bladder.

Hara I, Miyake H, Takechi Y, Eto H, Gotoh A, Fujisawa M, Okada H, Arakawa S, Kamidono S; Kobe Urogenital Tumor Study Group.

Int J Urol. 2003 Jan;10(1):19-24.

PMID:
12534921
[PubMed - indexed for MEDLINE]
13.

Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.

Raman JD, Ng CK, Boorjian SA, Vaughan ED Jr, Sosa RE, Scherr DS.

BJU Int. 2005 Nov;96(7):1031-5.

PMID:
16225523
[PubMed - indexed for MEDLINE]
14.

Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.

Ribal MJ, Alcaraz A, Mengual L, Carrio A, Lopez-Guillermo A, Mallofré C, Palou J, Gelabert A, Villavicencio H.

Eur Urol. 2004 May;45(5):593-9.

PMID:
15082201
[PubMed - indexed for MEDLINE]
15.

Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.

Orsola A, Trias I, Raventós CX, Español I, Cecchini L, Búcar S, Salinas D, Orsola I.

Eur Urol. 2005 Aug;48(2):231-8; discussion 238.

PMID:
15963635
[PubMed - indexed for MEDLINE]
16.

Predicting disease outcome of non-invasive transitional cell carcinoma of the urinary bladder using an artificial neural network model: results of patient follow-up for 15 years or longer.

Fujikawa K, Matsui Y, Kobayashi T, Miura K, Oka H, Fukuzawa S, Sasaki M, Takeuchi H, Okabe T.

Int J Urol. 2003 Mar;10(3):149-52.

PMID:
12622711
[PubMed - indexed for MEDLINE]
17.

Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.

Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P, Lugagne PM, Botto H.

J Urol. 2000 Jan;163(1):63-7.

PMID:
10604315
[PubMed - indexed for MEDLINE]
18.

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.

Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T; Cancer Registration Committee of the Japanese Urological Association.

Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.

PMID:
19207609
[PubMed - indexed for MEDLINE]
19.

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.

Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.

Br J Cancer. 2001 Jan;84(2):270-5.

PMID:
11161387
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Bladder tumours in Chinese: a 6 year study.

Lam KY, Chan AC, Chan KW.

Aust N Z J Surg. 1994 Aug;64(8):551-5.

PMID:
8048894
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk